Cipla acquires 100% stake in Inzpera Healthsciences
market hours1 source ↓written by the desknot a recommendation
- of Inzpera Healthsciences
- 100% acquisition
Cipla Ltd shares gained attention following the announcement of a 100% acquisition of Inzpera Healthsciences. This strategic move aims to enhance Cipla's presence in the paediatric market by leveraging Inzpera's portfolio of pharmaceutical and wellness products. The acquisition will make Inzpera a wholly-owned subsidiary, expected to drive growth and scalability.
Not investment advice. For informational purposes only.